✦ LIBER ✦

A phase II study of modified dose-dense paclitaxel and every 4 week carboplatin for the treatment of advanced stage primary epithelial ovarian, fallopian tube, or peritoneal carcinoma

✍ Scribed by L. Abaid; J. Micha; M. Rettenmaier; J. Brown; A. Mendivil; K. Lopez; B. Goldstein

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of cetuximab/paclitaxel

✍ Jason Konner; Russell J. Schilder; Felicia A. DeRosa; Scott R. Gerst; William P. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 226 KB

A phase II study of outpatient first-lin

✍ J.P. MICHA; B.H. GOLDSTEIN; M.A. RETTENMAIER; M. GENESEN; C. GRAHAM; K. BADER; K 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

A phase II evaluation of belinostat and

✍ Don S. Dizon; John A. Blessing; Richard T. Penson; Richard D. Drake; Joan L. Wal 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 197 KB

A phase II study of modified dose-dense paclitaxel and every 4&#xa0;week carboplatin for the treatment of advanced stage primary epithelial ovarian, fallopian tube, or peritoneal carcinoma